Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
Comparative Study Between Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient
National Cancer Institute, Egypt
128 participants
Jan 15, 2025
INTERVENTIONAL
Conditions
Summary
In current study the investigators aim to compare between nalbuphine versus tramadol for post-operative pain control in abdominal surgeries in pediatric.
Eligibility
Inclusion Criteria3
- Participants will be children aged 3-12 years
- American society of anesthesia (ASA) classification I-III.
- scheduled for elective Abdominal surgery under general anesthesia
Exclusion Criteria3
- child guardian refusal.
- Allergy from Tramal or nalbuphine
- Patient with previous chronic pain on opioids
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
this group will a single dose of nalbuphine (0.2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours)
this group will receive a single dose of tramadol (2 mg/kg) immediately after surgery to be repeated every 8 hours for the duration of the study (72 hours).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07110051